Search research articles
Contact Us
Filters
Showing results (21-30 of 106) with videos related to
Page
of 11
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2020
Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology
Ozge Gumusay, Pietro Paolo Vitiello, Chiara Wabl, et al.
Cancer Research
|
November 1, 2008
Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice
Ryan B Corcoran, Tal Bachar Raveh, Monique T Barakat, et al.
Science Signaling
|
November 25, 2010
BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation
Ryan B Corcoran, Dora Dias-Santagata, Kristin Bergethon, et al.
Radiology. Imaging Cancer
|
March 29, 2021
Radiomics Texture Features in Advanced Colorectal Cancer: Correlation with <i>BRAF</i> Mutation and 5-year Overall Survival
Adrian A Negreros-Osuna, Anushri Parakh, Ryan B Corcoran, et al.
Cancer Cell
|
January 30, 2026
Emerging landscape of KRAS inhibitors in cancer treatment
Jakob M Riedl, Hiroyuki Matsubara, Reid McNeil, et al.
Nature Communications
|
June 14, 2020
Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots
Pégah Jalili, Danae Bowen, Adam Langenbucher, et al.
Cancer Research
|
May 19, 2011
STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis
Ryan B Corcoran, Gianmarco Contino, Vikram Deshpande, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2019
Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRAS<sup>G12C</sup> Inhibition
Meagan B Ryan, Ferran Fece de la Cruz, Sarah Phat, et al.
Cell Reports
|
June 22, 2022
KRAS<sup>G12C</sup>-independent feedback activation of wild-type RAS constrains KRAS<sup>G12C</sup> inhibitor efficacy
Meagan B Ryan, Oluwadara Coker, Alexey Sorokin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2023
Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma
Qibiao Wu, Haley Ellis, Giulia Siravegna, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 106) with videos related to
Sort By:
Page
of 11
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2020
Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology
Ozge Gumusay, Pietro Paolo Vitiello, Chiara Wabl, et al.
Cancer Research
|
November 1, 2008
Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice
Ryan B Corcoran, Tal Bachar Raveh, Monique T Barakat, et al.
Science Signaling
|
November 25, 2010
BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation
Ryan B Corcoran, Dora Dias-Santagata, Kristin Bergethon, et al.
Radiology. Imaging Cancer
|
March 29, 2021
Radiomics Texture Features in Advanced Colorectal Cancer: Correlation with <i>BRAF</i> Mutation and 5-year Overall Survival
Adrian A Negreros-Osuna, Anushri Parakh, Ryan B Corcoran, et al.
Cancer Cell
|
January 30, 2026
Emerging landscape of KRAS inhibitors in cancer treatment
Jakob M Riedl, Hiroyuki Matsubara, Reid McNeil, et al.
Nature Communications
|
June 14, 2020
Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots
Pégah Jalili, Danae Bowen, Adam Langenbucher, et al.
Cancer Research
|
May 19, 2011
STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis
Ryan B Corcoran, Gianmarco Contino, Vikram Deshpande, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2019
Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRAS<sup>G12C</sup> Inhibition
Meagan B Ryan, Ferran Fece de la Cruz, Sarah Phat, et al.
Cell Reports
|
June 22, 2022
KRAS<sup>G12C</sup>-independent feedback activation of wild-type RAS constrains KRAS<sup>G12C</sup> inhibitor efficacy
Meagan B Ryan, Oluwadara Coker, Alexey Sorokin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2023
Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma
Qibiao Wu, Haley Ellis, Giulia Siravegna, et al.
Page
of 11